Phosphatidylcholine treatment to induce lipolysis
The medicine Lipostabil N
®
has been in widespread use in Europe since 2002 by doctors working in the field of esthetics to achieve a reduction in the volume of smaller fat deposits by means of injections into the subcutaneous fatty tissue.The lipases released from the adipocytes by means of PPC produce a
local breakdown of fat that is then discharged over the liver and metabolized via betaoxidation. The medicine has been authorized for i.v. use in the prophylaxis and
therapy of fat embolisms and liver diseases.
